Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
marketing approval
Marketing
FDA proposes yanking approval for AMAG Pharma's Makena
The FDA proposed withdrawing marketing approval for AMAG's Makena just days after the company agreed to a $647 million buyout from Clovis Group.
Kyle Blankenship
Oct 6, 2020 11:32am
Chiasma secures comeback FDA nod for acromegaly pill Mycapssa
Jun 26, 2020 1:30pm
Drugmakers blaze a path for new therapy launches during COVID-19
Jun 18, 2020 11:00am
FDA experts vote to pull AMAG's premature-birth med Makena
Oct 30, 2019 10:30am
FDA review of troubled drug could hobble AMAG in proxy fight
Sep 26, 2019 11:54am
NICE hands Novartis a gene therapy win with Luxturna backing
Sep 4, 2019 10:59am
